Professor Claire wainwright is the Head of Cystic Fibrosis (CF) services which provide state-wide services for around 420 children with CF across Queensland.  She also runs the respiratory service for the only national clinic caring for children with ataxia telangiectasia.  She has a long standing research interest in airway diseases, including bronchiolitis, asthma, cystic fibrosis and rare lung diseases.  Professor Wainwright conducted the first randomized trial of BAL-directed therapy to improve clinical outcomes in infants and young children with CF.  She has also been instrumental in the design and conduct of clinical trials that have brought ivacaftor and lumacaftor to the CF community.